Trials / Conditions / Hepatopulmonary Syndrome

Hepatopulmonary Syndrome

11 registered clinical trials studyying Hepatopulmonary Syndrome.

Status	Trial	Sponsor	Phase
Unknown	Efficacy and Safety of Pentoxifylline in Improving Oxygenation in Hepatopulmonary Syndrome NCT05373134	Institute of Liver and Biliary Sciences, India	N/A
Terminated	Letrozole in Patients With Hepatopulmonary Syndrome NCT04577001	Mayo Clinic	Phase 2
Unknown	Supine Exercise in Hepatopulmonary Syndrome Patients With Orthodeoxia NCT04004104	Unity Health Toronto	N/A
Unknown	Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Wes NCT03435406	Southwest Hospital, China	—
Unknown	Hepatopulmonary Syndrome and Postoperative Complications After Liver Transplantation : A Case-control Study NCT03092401	Hospices Civils de Lyon	—
Completed	Effect of Transjugular Intrahepatic Portosystemic Shunt on Oxygenation in Cirrhotic Patients With Hepatopulmon NCT02148536	West China Hospital	—
Terminated	Sorafenib for Hepatopulmonary Syndrome NCT02021929	University of Pennsylvania	Phase 2
Unknown	Efficacy of Pentoxifylline and Rifaximin Combination in Pentoxifylline Refractory Clinical and Subclinical Hep NCT01676597	Institute of Liver and Biliary Sciences, India	N/A
Terminated	Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis NCT01518595	Medical University of Vienna	Phase 2
Completed	A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome NCT00362752	Unity Health Toronto	Phase 2
Terminated	Pilot Study of Pentoxifylline for Hepatopulmonary Syndrome NCT00593658	University of Alabama at Birmingham	Phase 1